West Pharmaceutical Services Stock – Fundamental Analysis
Fundamental Data & Ratios (Balance sheet update: 10/2/2026)
| Balance Sheet | Total Assets | 4,270,000,000.00 | ROE | 74.38 % |
| Balance Sheet | Total Equity | 3,176,000,000.00 | ROA | 11.56 % |
| Cashflow | Capital Expenditures | -285,900,000.00 | P/FCF | 58.09 |
| Cashflow | Free Cash Flow | 468,900,000.00 | – | – |
| Cashflow | Operating Cash Flow | 754,800,000.00 | P/CF | 36.09 |
| Income | Earnings per Share (diluted) | 6.79 | Div. Yield | 0.23 % |
| Income | Net Income | 493,700,000.00 | P/E | 55.18 |
| Income | Shares Outstanding | 72,000,000.00 | P/B | 8.58 |
| Income | Total Revenue | 3,074,100,000.00 | P/S | 8.86 |
Ratios calculated on: 10/14/2026
Company Description
West Pharmaceutical Services, Inc. designs and produces containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.westpharma.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more